OTHER FUNCTIONS R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH), UNIVERSAL REAGENT SET
$998,116N44FY2012CANIH
Solulink Biosciences, San Diego CA
Investigators
Abstract
Our multiplex IHC assays are aimed to more accurately detect basal-like breast cancer associated iwth lower disease-free survival and overall survival. The goal is to develop an automated assay by incorporating our assay into commercially available automated instruments that stain, scan and analyze the sample.
View original record on NIH RePORTER →